{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T04:42:16Z","timestamp":1653108136114},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s13139-015-0361-1","type":"journal-article","created":{"date-parts":[[2015,8,31]],"date-time":"2015-08-31T09:16:08Z","timestamp":1441012568000},"page":"276-283","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Correlation of Consecutive Serum Thyroglobulin Levels During Hormone Withdrawal and Failure of Initial Radioiodine Ablation in Thyroid Cancer Patients"],"prefix":"10.1007","volume":"49","author":[{"given":"Hyukjin","family":"Yoon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joo Hyun","family":"O","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye Young","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeongjoo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyoungwoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiyoung","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,1]]},"reference":[{"issue":"11","key":"361_CR1","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1089\/thy.2009.0110","volume":"19","author":"DS Cooper","year":"2009","unstructured":"Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid: Off J Am Thyroid Assoc. 2009;19(11):1167\u2013214.","journal-title":"Thyroid: Off J Am Thyroid Assoc"},{"issue":"5","key":"361_CR2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1530\/eje.1.02014","volume":"153","author":"F Pacini","year":"2005","unstructured":"Pacini F, Schlumberger M, Harmer C, Berg GG, Cohen O, Duntas L, et al. Post-surgical use of radioiodine (131I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus report. Eur J Endocrinol\/Eur Fed Endocrine Soc. 2005;153(5):651\u20139.","journal-title":"Eur J Endocrinol\/Eur Fed Endocrine Soc"},{"key":"361_CR3","doi-asserted-by":"crossref","unstructured":"Sawka AM, Brierley JD, Tsang RW, Thabane L, Rotstein L, Gafni A, et al. An updated systematic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer. Endocrinol Metab Clin North Am. 2008;37(2):457\u201380.","DOI":"10.1016\/j.ecl.2008.02.007"},{"issue":"1","key":"361_CR4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1530\/eje.1.01819","volume":"152","author":"FA Verburg","year":"2005","unstructured":"Verburg FA, de Keizer B, Lips CJ, Zelissen PM, de Klerk JM. Prognostic significance of successful ablation with radioiodine of differentiated thyroid cancer patients. Eur J Endocrinol\/Eur Fed Endocrine Soc. 2005;152(1):33\u20137.","journal-title":"Eur J Endocrinol\/Eur Fed Endocrine Soc"},{"issue":"3","key":"361_CR5","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/j.semnuclmed.2006.03.002","volume":"36","author":"P Lind","year":"2006","unstructured":"Lind P, Kohlfurst S. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer. Semin Nucl Med. 2006;36(3):194\u2013205.","journal-title":"Semin Nucl Med"},{"issue":"6","key":"361_CR6","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/RLU.0b013e31824852f8","volume":"37","author":"DB Kendler","year":"2012","unstructured":"Kendler DB, Vaisman F, Corbo R, Martins R, Vaisman M. Preablation stimulated thyroglobulin is a good predictor of successful ablation in patients with differentiated thyroid cancer. Clin Nucl Med. 2012;37(6):545\u20139.","journal-title":"Clin Nucl Med"},{"key":"361_CR7","doi-asserted-by":"crossref","unstructured":"Lin YS, Li TJ, Liang J, Li XY, Qiu LH, Wang SS, et al. Predictive value of preablation stimulated thyroglobulin and thyroglobulin\/thyroid-stimulating hormone ratio in differentiated thyroid cancer. Clin Nucl Med. 2011;36(12):1102\u20135.","DOI":"10.1097\/RLU.0b013e3182291c65"},{"issue":"4","key":"361_CR8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s13139-014-0282-4","volume":"48","author":"HJ Park","year":"2014","unstructured":"Park HJ, Jeong G-C, Kwon SY, Min J-J, Bom H-S, Park KS, et al. Stimulated serum thyroglobulin level at the time of first dose of radioactive iodine therapy is the most predictive factor for therapeutic failure in patients with papillary thyroid carcinoma. Nucl Med Mol Imaging. 2014;48(4):255\u201361.","journal-title":"Nucl Med Mol Imaging"},{"issue":"12","key":"361_CR9","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1007\/s00259-005-1866-0","volume":"32","author":"MO Bernier","year":"2005","unstructured":"Bernier MO, Morel O, Rodien P, Muratet JP, Giraud P, Rohmer V, et al. Prognostic value of an increase in the serum thyroglobulin level at the time of the first ablative radioiodine treatment in patients with differentiated thyroid cancer. Eur J Nucl Med Mol Imaging. 2005;32(12):1418\u201321.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"361_CR10","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1007\/s00259-013-2370-6","volume":"40","author":"L Giovanella","year":"2013","unstructured":"Giovanella L, Trimboli P, Verburg FA, Treglia G, Piccardo A, Foppiani L, et al. Thyroglobulin levels and thyroglobulin doubling time independently predict a positive 18F-FDG PET\/CT scan in patients with biochemical recurrence of differentiated thyroid carcinoma. Eur J Nucl Med Mol Imaging. 2013;40(6):874\u201380.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"361_CR11","doi-asserted-by":"crossref","unstructured":"Valle LA, Baskin RLG, Porter K, Sipos JA, Khawaja R, Ringel MD, et al. In thyroidectomized patients with thyroid cancer, a serum thyrotropin of 30 mu U\/ml after thyroxine withdrawal is not always adequate for detecting an elevated stimulated serum thyroid: Off J Am Thyroid Assoc. 2013;23(2):185\u201393.","DOI":"10.1089\/thy.2012.0327"},{"issue":"2","key":"361_CR12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1046\/j.1365-2265.2002.01592.x","volume":"57","author":"JK Chung","year":"2002","unstructured":"Chung JK, Park YJ, Kim TY, So Y, Kim SK, Park DJ, et al. Clinical significance of elevated level of serum antithyroglobulin antibody in patients with differentiated thyroid cancer after thyroid ablation. Clin Endocrinol. 2002;57(2):215\u201321.","journal-title":"Clin Endocrinol"},{"issue":"8","key":"361_CR13","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1210\/jc.2004-0986","volume":"89","author":"CA Spencer","year":"2004","unstructured":"Spencer CA. Editorial: Challenges of serum thyroglobulin (Tg) measurement in the presence of Tg autoantibodies. J Clin Endocrinol Metab. 2004;89(8):3702\u20134.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"361_CR14","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s12149-012-0640-1","volume":"26","author":"I Lim","year":"2012","unstructured":"Lim I, Kim SK, Hwang SS, Kim SW, Chung KW, Kang HS, et al. Prognostic implication of thyroglobulin and quantified whole body scan after initial radioiodine therapy on early prediction of ablation and clinical response for the patients with differentiated thyroid cancer. Ann Nucl Med. 2012;26(10):777\u201386.","journal-title":"Ann Nucl Med"},{"issue":"5","key":"361_CR15","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1210\/jc.2010-2708","volume":"96","author":"M Brassard","year":"2011","unstructured":"Brassard M, Borget I, Edet-Sanson A, Giraudet AL, Mundler O, Toubeau M, et al. Long-term follow-up of patients with papillary and follicular thyroid cancer: a prospective study on 715 patients. J Clin Endocrinol Metab. 2011;96(5):1352\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"361_CR16","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1089\/thy.2010.0355","volume":"21","author":"A Miyauchi","year":"2011","unstructured":"Miyauchi A, Kudo T, Miya A, Kobayashi K, Ito Y, Takamura Y, et al. Prognostic impact of serum thyroglobulin doubling-time under thyrotropin suppression in patients with papillary thyroid carcinoma who underwent total thyroidectomy. Thyroid: Off J Am Thyroid Assoc. 2011;21(7):707\u201316.","journal-title":"Thyroid: Off J Am Thyroid Assoc"},{"issue":"4","key":"361_CR17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1507\/endocrj.EJ12-0363","volume":"60","author":"A Miyauchi","year":"2013","unstructured":"Miyauchi A, Kudo T, Kihara M, Higashiyama T, Ito Y, Kobayashi K, et al. Relationship of biochemically persistent disease and thyroglobulin-doubling time to age at surgery in patients with papillary thyroid carcinoma. Endocr J. 2013;60(4):415\u201321.","journal-title":"Endocr J"},{"issue":"2","key":"361_CR18","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/MNM.0000000000000025","volume":"35","author":"A Kelders","year":"2014","unstructured":"Kelders A, Kennes LN, Krohn T, Behrendt FF, Mottaghy FM, Verburg FA. Relationship between positive thyroglobulin doubling time and F-18-FDG PET\/CT-positive, I-131-negative lesions. Nucl Med Commun. 2014;35(2):176\u201381.","journal-title":"Nucl Med Commun"},{"issue":"11","key":"361_CR19","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1245\/s10434-012-2391-6","volume":"19","author":"H Wong","year":"2012","unstructured":"Wong H, Wong KP, Yau T, Tang V, Leung R, Chiu J, et al. Is there a role for unstimulated thyroglobulin velocity in predicting recurrence in papillary thyroid carcinoma patients with detectable thyroglobulin after radioiodine ablation? Ann Surg Oncol. 2012;19(11):3479\u201385.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"361_CR20","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s12149-014-0927-5","volume":"29","author":"YI Kim","year":"2015","unstructured":"Kim YI, Im HJ, Paeng J, Cheon G, Kang K, Lee D, et al. Serum thyroglobulin level after radioiodine therapy (day 3) to predict successful ablation of thyroid remnant in postoperative thyroid cancer. Ann Nucl Med. 2015;29(2):184\u20139.","journal-title":"Ann Nucl Med"},{"issue":"18","key":"361_CR21","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1056\/NEJMoa1109589","volume":"366","author":"U Mallick","year":"2012","unstructured":"Mallick U, Harmer C, Yap B, Wadsley J, Clarke S, Moss L, et al. Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer. N Engl J Med. 2012;366(18):1674\u201385.","journal-title":"N Engl J Med"},{"issue":"3","key":"361_CR22","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s12020-012-9729-5","volume":"42","author":"L Wartofsky","year":"2012","unstructured":"Wartofsky L, Van Nostrand D. Radioiodine treatment of well-differentiated thyroid cancer. Endocrine. 2012;42(3):506\u201313.","journal-title":"Endocrine"}],"container-title":["Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13139-015-0361-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13139-015-0361-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13139-015-0361-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T03:59:47Z","timestamp":1653105587000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13139-015-0361-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,1]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["361"],"URL":"https:\/\/doi.org\/10.1007\/s13139-015-0361-1","relation":{},"ISSN":["1869-3474","1869-3482"],"issn-type":[{"value":"1869-3474","type":"print"},{"value":"1869-3482","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,1]]}}}